Top Markets
Coin of the day
Acepodia, Inc. Acepodia, Inc.

Acepodia, Inc.

6976
Rank in Stocks #17936
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Share Price
$0.37840843
Market Cap
$219.66M
Change (1 day)
-0.42%
Change (1 year)
-27.25%
Country
KY
Trade Acepodia, Inc. (6976)

Category

P/S ratio for Acepodia, Inc. (6976)
P/S ratio as of 2026 TTM: 0
According to Acepodia, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Acepodia, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.95 -
US
12.19 -
NL
24.99 -
US
3.75 -
AU
- -
CH